Kinloch Capital LLC Purchases 790 Shares of Aflac Incorporated (NYSE:AFL)

Kinloch Capital LLC boosted its position in Aflac Incorporated (NYSE:AFL) by 1.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 49,122 shares of the financial services provider’s stock after acquiring an additional 790 shares during the period. Aflac accounts for about 2.5% of Kinloch Capital LLC’s holdings, making the stock its 7th biggest position. Kinloch Capital LLC’s holdings in Aflac were worth $5,081,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Private Trust Co. NA boosted its stake in Aflac by 1.3% during the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock valued at $791,000 after purchasing an additional 99 shares during the last quarter. Phillips Wealth Planners LLC lifted its holdings in shares of Aflac by 1.5% in the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock valued at $662,000 after purchasing an additional 100 shares in the last quarter. Raleigh Capital Management Inc. boosted its position in shares of Aflac by 23.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after buying an additional 100 shares during the last quarter. TKG Advisors LLC grew its holdings in Aflac by 0.5% during the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock worth $2,230,000 after buying an additional 103 shares in the last quarter. Finally, Robertson Stephens Wealth Management LLC raised its position in Aflac by 1.6% in the 4th quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider’s stock valued at $720,000 after buying an additional 107 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on AFL shares. JPMorgan Chase & Co. upped their target price on shares of Aflac from $94.00 to $96.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 2nd. Barclays increased their price objective on shares of Aflac from $95.00 to $96.00 and gave the company an “underweight” rating in a research note on Thursday, May 1st. UBS Group lifted their target price on shares of Aflac from $109.00 to $114.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 2nd. Piper Sandler boosted their target price on Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 2nd. Finally, StockNews.com downgraded Aflac from a “hold” rating to a “sell” rating in a research report on Monday, May 5th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $104.57.

Aflac Stock Down 0.4%

Shares of NYSE AFL opened at $106.34 on Tuesday. The business’s fifty day moving average price is $107.04 and its 200-day moving average price is $106.49. Aflac Incorporated has a one year low of $86.46 and a one year high of $115.50. The stock has a market capitalization of $57.49 billion, a PE ratio of 11.08, a P/E/G ratio of 3.24 and a beta of 0.84. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts’ consensus estimates of $1.67 by ($0.01). The business had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a return on equity of 16.20% and a net margin of 28.76%. Aflac’s revenue for the quarter was down 37.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.66 EPS. On average, equities research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 2nd. Investors of record on Wednesday, May 21st will be paid a $0.58 dividend. The ex-dividend date is Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a yield of 2.18%. Aflac’s dividend payout ratio is 36.25%.

Insider Buying and Selling at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares of the company’s stock, valued at $2,733,048.59. This trade represents a 3.79% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Arthur Reginald Collins sold 2,750 shares of the business’s stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total transaction of $290,675.00. Following the transaction, the director now owns 6,728 shares of the company’s stock, valued at $711,149.60. This trade represents a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 34,552 shares of company stock valued at $3,702,552 in the last 90 days. 0.90% of the stock is currently owned by company insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.